Sebby Borriello Email and Phone Number
Sebby Borriello work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Sebby Borriello personal email
30+ years of experience and a distinguished record of results in key leadership positions across the pharmaceutical and medical device industries which include, the development and execution of strategic initiatives, a track record of impact, high performance, and turnarounds across global/domestic and public/private companies with a focus on commercialization strategy, talent development, & culture creation to maximize business results. In June 2021, I started a consulting firm, MVP3, People, Products and Process, the 3 key elements for any organization to be successful and thrive. The firm’s focus will be providing commercial (sales & marketing) consulting, advisory and management board services for biotech and medical device companies.
Midas Healthcare Solutions, Inc.
View-
Executive Vice President, Chief Commercial OfficerMidas Healthcare Solutions, Inc. Apr 2023 - PresentNew York, Ny, UsMIDAS Healthcare Solutions is poised to provide the first comprehensive solution to aid in the prevention of medication theft and abuse, also known as diversion, in healthcare institutions and homes. -
Member Of The Board Of AdvisorsMidas Healthcare Solutions, Inc. Jan 2023 - Apr 2023New York, Ny, UsMIDAS Healthcare Solutions is poised to provide the first comprehensive solution to aid in the prevention of medication theft and abuse, also known as diversion, in healthcare institutions and homes. -
Commercial Strategy AdvisorZymedi Mar 2022 - PresentThe mission is to identify novel therapeutics for life-threatening diseases that have no standard of care or lack effective therapy. Dedicated to treating diseases with significant unmet needs by expanding the promise of precision medicine.In 2019, we were the first-and-only global pharmaceutical company focused on the noncatalytic regulatory roles of aminoacyl-tRNA synthetases (ARSs) as novel therapeutic targets for the most challenging-to-treat diseases. Today, the pioneering efforts continue to show promise across a number of disease states and countless targets. -
Consultant/AdvisorMvp3, People, Product, Process, Llc. Jun 2021 - PresentSenior Executive with distinguished record of results in key leadership positions across the pharmaceutical and medical device industries. Providing guidance in developing strategy across the healthcare sector and refocusing pharmaceutical and medical device organizations for success. Strong track record of impact, high performance, and turnarounds across global/domestic and public/private companies, with a focus on commercialization strategy, talent development, & culture creation.
-
Commercial/Bd AdvisorCarmell Therapeutics Sep 2021 - Feb 2023Pittsburgh, Pa, Ushttps://www.businesswire.com/news/home/20220511005042/en/Carmell-Therapeutics-Announces-the-Appointment-of-Sebastian-%E2%80%9CSebby%E2%80%9D-Borriello-to-Chief-Business-OfficerIts an honor to join Carmell and it distinguished leadership team. Our Groundbreaking Plasma-based Bioactive Materials (PBMs) are Designed to Improve Patient Outcomes and Thereby Potentially Reduce Healthcare Costs Across a Variety of Clinical Settings -
Vice President, Chief Commercial OfficerSk Life Science, Inc. Sep 2016 - May 2021Recruited to evolve the company from a pure R&D/clinical organization to fully integrated pharmaceutical company with commercial capabilities • Built commercial infrastructure and organization for successful market adoption of company’s future product launches which include sales, marketing, commercial operations, market access, and trade• Led development and execution of commercialization strategy• Launched XCOPRI® (cenobamate) for Focal Seizures in Adults in May 2020• Successful XCOPRI® launch (through April 2021). NBRxs and TRxs have outpaced the previous 3 product launches for Focal Seizures in Adults. This is particularly noteworthy given the XCOPRI® product launch took place during the COVID-19 global pandemic• Presented the XCOPRI® U.S. value proposition during the SK biopharmaceutical IPO deal roadshow in June 2020. IPO raised ~$880M USD and generated the most investor demand in the history of Korean Stock Exchange IPOs
-
Vice President, Market DevelopmentCempra Pharmaceuticals Sep 2014 - Aug 2016Chapel Hill, North Carolina, Us• Crafted marketing materials and sales strategies for launch of Solithromycin • Organized advisory and consultant meetings• Built strategic relationships with key stakeholders in medical community • Recruited market development personnel -
Us Vp Sales And MarketingMentor Worldwide, Llc, A Johnson & Johnson Company May 2011 - Aug 2014US VP Sales and Marketing (9/2012-9/2014) • Oversaw over $240M in sales of medical products for the aesthetic market• Managed a team of 150 sales and marketing employeesNational Sales Director (5/2011-8/2012) • Led the launch of four new commercial products in 12 months, resulting in $20M in incremental revenue • Prioritized drive of hospital sales, which surpassed private practice sales for first time in company history• Collaborated with Ethicon to expand into new growth areas within plastic surgery channel• Managed sales force of 120 associates -
Vp Account ManagementJohnson & Johnson Health Care Systems Inc. Jan 2010 - Apr 2011Piscataway, New Jersey, Us• Led company collaboration across the IDN, Government and GPO channels for 94 Medical Device, Pharmaceutical, and Consumer accounts• Evolved business strategies of medical device sector with large IDNs • Enhanced the account management competency model, resulting in a talent upgrade -
World Wide Director Of Marketing Biopatch Products, J&J Wound ManagementEthicon, Inc. Feb 2004 - Dec 2009World Wide Director of Marketing BioPatch Products, J&J Wound Management (7/2008-12/2009)• Oversaw regulatory approval for the sales and marketing of Biopatch for new markets in EMEA and AP • Grew outside US revenue of BioPatch brand by 47%• Assembled and trained sales and marketing teams in Middle East, Latin America, Canada and Australia Director Sales & Marketing, J&J Biosurgicals (1/2006-6/2008) • Oversaw talent acquisition for key positions, including Region Sales Director, Group Product Director and Marketing Directors• Grew business plan by 21% over previous year Director Sales & Marketing, J&J Advanced Wound Care (AWC) (3/2005-12/2005) • Led AWC to 38% growth in sales over previous year, its best year yet• Created 57% growth for “Activities/Specialty Dressing” device portfolio• Managed a 50 person sales forceNational Sales Director, J&J Advanced Wound Care (2/2004-2/2005) • Restructured sales focus and incorporated new targets• Introduced “Field Coach Process” to sales management team to improve performance and accountability • Tripled the size of dedicated BioPatch sales force
-
Field Sales Director, Central Nervous System Specialty (Cns)Ortho-Mcneil Pharmaceutical Apr 1987 - Jan 2004Jakarta, Id• Held a variety of sales and business development roles over the course of 17 years, overseeing regional sales and marketing efforts• Managed 48% increase in sales growth in both 2002 and 2003 for TOPAMAX brand, resulting in $804M total sales in 2003; Almost doubled CNS specialty sales force in 2003• Lead for the American Academy of Neurology (AAN) • Improved third party reimbursement from 30% to 65% in 7 months• Led all 10 regions in LEVAQUIN sales for 2 years in a row• Performed among top 3 regions for ULTRAM sales performance• Developed training materials for product launch of ULTRAM AND TOPAMAX; Crafted new training material for Anti-Infective hospital selling • Developed the Partnership for Appropriate Quinolone Therapy (PAQT) contract strategy for FLOXIN, which is attributed to Ortho-McNeil’s leadership in the hospital marketplace• Elevated last performing district in country to a top 10 finish in 1992• Led acute care accounts in Northeast Launched FLOXIN in hospital market; Led sales in Queens, NY for analgesics, oral contraceptives and anti-psychotic products
Sebby Borriello Skills
Sebby Borriello Education Details
-
University Of PennsylvaniaOrganizational Dynamics -
St. John'S UniversityPolitical Science/Public Administration -
New Utrecht
Frequently Asked Questions about Sebby Borriello
What company does Sebby Borriello work for?
Sebby Borriello works for Midas Healthcare Solutions, Inc.
What is Sebby Borriello's role at the current company?
Sebby Borriello's current role is Executive Vice President, Chief Commercial Officer Midas Healthcare Solutions, Inc..
What is Sebby Borriello's email address?
Sebby Borriello's email address is sebbyborriello@sk.com
What schools did Sebby Borriello attend?
Sebby Borriello attended University Of Pennsylvania, St. John's University, New Utrecht.
What skills is Sebby Borriello known for?
Sebby Borriello has skills like Medical Devices, Product Launch, Market Development, Pharmaceutical Sales, Pharmaceutical Industry, Sales, Strategy, Cross Functional Team Leadership, Surgeons, Sales Effectiveness, Managed Care, Capital Equipment.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial